Trademark: 90151421
Word
EFTEKI
Status
Registered
Status Code
700
Status Date
Tuesday, September 13, 2022
Serial Number
90151421
Registration Number
6841826
Registration Date
Tuesday, September 13, 2022
Mark Type
4000
Filing Date
Tuesday, September 1, 2020
Published for Opposition
Tuesday, June 28, 2022

Trademark Owner History

Classifications
5 Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets

Trademark Events
Sep 13, 2022
Notice Of Registration Confirmation Emailed
Sep 13, 2022
Registered-Principal Register
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Published For Opposition
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
May 18, 2022
Approved For Pub - Principal Register
May 17, 2022
Teas/Email Correspondence Entered
May 17, 2022
Correspondence Received In Law Office
May 17, 2022
Assigned To Lie
May 12, 2022
Teas Response To Suspension Inquiry Received
Dec 1, 2021
Notification Of Inquiry As To Suspension E-Mailed
Dec 1, 2021
Inquiry To Suspension E-Mailed
Dec 1, 2021
Suspension Inquiry Written
Nov 24, 2021
Suspension Checked ¿ To Attorney For Action
May 24, 2021
Notification Of Letter Of Suspension E-Mailed
May 24, 2021
Letter Of Suspension E-Mailed
May 24, 2021
Suspension Letter Written
May 12, 2021
Assigned To Examiner
Mar 31, 2021
Teas/Email Correspondence Entered
Mar 30, 2021
Correspondence Received In Law Office
Mar 30, 2021
Teas Response To Office Action Received
Jan 8, 2021
Notification Of Non-Final Action E-Mailed
Jan 8, 2021
Non-Final Action E-Mailed
Jan 8, 2021
Non-Final Action Written
Jan 5, 2021
Assigned To Examiner
Oct 6, 2020
New Application Office Supplied Data Entered In Tram
Sep 4, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24